Drugs incorporated into the Brazilian Unified Health System: document analysis of methodological decisions in budget impact analyses between 2012 and 2024
The findings indicate that methodological inconsistencies persist in BIAs, such as the absence of sensitivity analyses and cost analyses limited to the acquisition cost of drugs. Therefore, it is suggested that there may be weaknesses in the estimates of the real budget impacts of technologies on the SUS.
Authors
- Everton Nunes da Silva (ORCID: https://orcid.org/0000-0001-8747-4185)
- Daniel da Silva Pereira Curado (ORCID: https://orcid.org/0000-0002-5965-4194)
Institutions
- Universidade de Brasília (BR)
- Ministério da Saúde (BR)
Publication Details
- Journal
- Epidemiologia e Serviços de Saúde
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1590/s2237-96222025v34e20250122.en
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00